2002

• Linda Suydam, DPA, Senior Associate Commissioner, FDA
• U.S. Representative Mark Foley (R-FL)
• U.S. Representative John M. Shimkus (R-IL)
• U.S. Representative Henry Waxman (D-CA)
• Actelion Pharmaceuticals US, Inc.
• AstraZeneca
• The Medtronic Foundation
• ILEX Oncology, Inc.
• Millennium Pharmaceuticals, Inc.
• Novartis Pharmaceuticals

2001

• U.S.Congressman Senator David R. Obey
• Dr. Robert J. Temple, FDA Director Office of Medical Policy
• Dr. Roscoe O. Brady, NIH Chief of Developmental and Metabolic Neurology
• Kay Holcombe, Executive Vice President of Policy Directions
• Cell Therapeutics, Inc.
• InterMune
• Orphan Medical, Inc.
• General Cologne Re Corporation
• Transkaryotic Therapies, Inc.

2000

• U.S. Representative John D. Dingell
• U.S. Representative Charles Norwood
• Christopher C. Jennings, Assistant to the President for Health Policy Development
• Frank Sasinowski, Hyman, Phelps & McNamara P.C.
• Nancy Harris, Chairperson NORD Board of Directors
• Elan Pharmaceuticals
• INO Therapeutics, Inc.
• Orphan Pharmaceuticals U.S.A., Inc.

1999

• U.S. Senator Dianne Feinstein
• Jane E. Henney, M.D., Commissioner, Food and Drug Administration
• Agnes Varis, President, Agvar Chemicals, Inc.
• Curt Engelhorn, President, European Foundation for the Advancement of Medicine and the Engelhorn Foundation for Rare Diseases
• Celgene Corporation
• Centocor, Inc.
• Cephalon, Inc.

1998

• Larry King, CNN
• U.S. Congresswoman Senator Louise M. Slaughter
• U.S. Congressman Robert Matsui
• Stephen C. Groft, Pharm.D, Director, NIH Office of Rare Diseases
• Lars-Uno Larsson, President and CEO, Swedish Orphan, AB
• Genetics Institute, Inc.
• PathoGenesis Corporation

1997

• U.S. Senator Richard L. Durbin
• U.S. Congressman Christopher Shays
• William V. Corr, Chief of Staff, U.S. Department of Health and Human Services
• MedImmune
• Rhone-Poulenc Rorer
• Ucyclyd Pharma

1996

• U.S. Senator James M. Jeffords
• W. French Anderson, M.D., Gene Therapy Pioneer
• Marlene Haffner, M.D., M.P.H., Director, FDA Office of Orphan Products Development
• Glaxo Wellcome, Inc.
• Orphan Medical, Inc.

1995

• Harold Varmus, M.D., Director, National Institutes of Health
• Carol Hampton Rasco, Domestic Policy Advisor to the President
• Jess G. Thoene, M.D., Professor of Pediatrics, University of Michigan
• Past Chairman of the Board of NORD
• Ken Larsen, President, Copley Pharmaceutical, Inc.
• Mylan Pharmaceuticals, Inc.
• Genetic Therapy, Inc.

1994

• Philip R. Lee, M.D., Assistant Secretary of Health, Department of Health & Human Services
• Francis S. Collins, M.D., Ph.D., Director, National Center for Human Genome Research, National Institutes of Health
• Larry Thompson, Author, Correcting the Code: Inventing the Genetic Cure for the Human Body
• Miles, Inc.
• Roberts Pharmaceutical

1993

• U.S. Senator Nancy L. Kassebaum
• U.S. Congressman Henry A. Waxman
• Jack Klugman, Actor
• Bruce Fried, Senior Vice President & Deputy Council, The Wexler Group
• Melvin Van Woert, M.D., Neurologist & Pharmacologist, Mt. Sinai School of Medicine
• Bristol-Myers Squibb Company
• Mission Pharmacal Company

1992

• David Kessler, M.D., J.D., Commissioner, Food and Drug Administration
• Allergan, Inc.
• Teva/Lemmon/Gate Pharmaceuticals
• Sigma-Tau Pharmaceuticals, Inc.

1991

• U.S. Senator Mark O. Hatfield
• Theodore Cooper, M.D., Chairman of the Board and Chief Executive Officer, The Upjohn Company
• Marion Finkel, M.D., Vice President, Sandoz Pharmaceuticals
• Enzon, Inc.
• Schering-Plough Company

1990

• U.S. Senator Tom Harkin
• U.S. Congressman Silvio Conte
• Jacob Schein, Chairman of the Board Schien Laboratories
• James B. Wyngaarden, M.D.
• Burroughs Wellcome Company
• Somerset Pharmaceuticals, Inc.

1989

• U.S. Congressman Doug Walgreen
• American Airlines
• Warner-Lambert Company
• Kendall-McGaw Laboratories

1988

• U.S. Senator Lowell P. Weicker, Jr.
• Frank Young, M.D., Commissioner, Food and Drug Administration
• Alice Fordyce, Executive Vice President, Albert and Mary Lasker Foundation
• Merck & Company
• Lyphomed, Inc.
• Sandoz Pharmaceuticals

1987

• U.S. Senator Orrin Hatch
• U.S. Congressman Jamie L. Whitten
• Bristol-Myers Squibb Company
• Hoffman-LaRoche
• Revco Drug Stores

1986

• U.S. Senator Nancy L. Kassebaum
• U.S. Senator Howard Metzenbaum
• U.S. Congressman Henry A. Waxman